spacer
home > pmps > winter 2018 > cool cargo
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cool Cargo

How important is a strong cold chain when transporting sensitive products and why?

To protect these high-value products, we have developed a complete logistical process to maintain shipment integrity. We remain committed to ensuring these temperature-sensitive pharmaceutical products are transported seamlessly, that the secure cool chain remains unbroken, and pharma goods are delivered fit for purpose.

All healthcare products are highly sensitive to environmental factors, such as temperature, humidity, pressure, and sunlight, and require specialised handling and operational procedures. Any fluctuations or exposure to these elements will affect the efficacy of pharmaceuticals, hence a seamless cool chain is paramount in the transportation of these.

What role do staff play in this procedure?

Compromised cold chain and temperature excursions can decrease the efficacy of the product, lead to product loss, and even jeopardise the safety of the patient. Hence, staff play a crucial role in maintaining a seamless cool chain, ensuring speed of delivery, security, temperature integrity, and control, as well as minimal exposure to environmental risks such as temperature extremes. Complex product offerings involve several levels of process integration and coordination over a broad spectrum from sales, operations, partners such as ground handlers, ramp handlers, special equipment suppliers, customer service, trainers, and so on.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Guillaume Halleux is the Acting Chief Officer Cargo at Qatar Airways. Bringing with him 20 years of vast knowledge and experience in the air cargo business, he joined the company as Vice President Asia Pacific in June 2016. Based in Singapore, Guillaume was responsible for driving cargo sales and operations in more than 15 countries in the region before joining the senior leadership team at Qatar Airways Cargo’s Doha head office in October 2017. He studied economics in France and holds a master’s in business administration from ICN Business School in Nancy, France.
spacer
Guillaume Halleux
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2018 Call for Entries – Deadline 31st July

The PPMA Group Industry Awards, which recognise manufacturing excellence, technical innovation, entrepreneurship as well as outstanding achievement and contribution to the industry, will this year take place at a new venue – the Hilton Birmingham Metropole Hotel at the NEC - on the 25th September 2018.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

 
Industry Events

SMI Immuno-Oncology Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement